From Don Margolis at the Repair Stem Cell Institute:
ESCs have no interest in sticking around and helping — they have but one
interest, to grow into a baby. . . .
To summarize — this is how far ESCs research has to go:
- Discover a way to avoid the need to destroy the patient’s immune system.
- Discover a way to “teach” these cells to continue to repair rather than proliferate, or
- Discover a way to “turn off” the cells before they become tumors.
- Discover a way to avoid the enormous cost in time and money to produce a trained ESC, something embryonic scientists never mention. America’s largest embryonic stem cell company tells investors quite clearly, in an SEC-required document, that the cost of its product may be too high to sell.